Literature DB >> 15767033

X-ray contrast media--an overview.

Cathrine Christiansen1.   

Abstract

X-ray contrast media are chemically inert drugs which are given intravascularly in very high amounts within a very short time period. Although they are regarded as relatively safe drugs, adverse reactions can occur: these are normally divided into immediate and delayed reactions. The latter appear hours to days after injection. Immediate reactions have been drastically reduced since the introduction of non-ionic monomers and non-ionic dimers. However, the delayed reactions still occur in a frequency of 1-3% in X-ray contrast media exposed patients. The majority of these reactions are mild and manifest as skin eruption, but severe reactions can also occur. Further improvement of the safety of these drugs is only possible with a better understanding of etiologies behind the observed adverse reactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767033     DOI: 10.1016/j.tox.2004.12.020

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  33 in total

Review 1.  Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist.

Authors:  Jeffrey J Pasternak; Eric E Williamson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

2.  Evaluation of adverse reactions to contrast media in the hospital.

Authors:  E-J Kyung; J-H Ryu; E-Y Kim
Journal:  Br J Radiol       Date:  2013-11-04       Impact factor: 3.039

3.  Synthesis and Preclinical Characterization of a Cationic Iodinated Imaging Contrast Agent (CA4+) and Its Use for Quantitative Computed Tomography of Ex Vivo Human Hip Cartilage.

Authors:  Rachel C Stewart; Amit N Patwa; Hrvoje Lusic; Jonathan D Freedman; Michel Wathier; Brian D Snyder; Ali Guermazi; Mark W Grinstaff
Journal:  J Med Chem       Date:  2017-06-27       Impact factor: 7.446

Review 4.  Diagnostic and prognostic utility of non-invasive imaging in diabetes management.

Authors:  Cristina Barsanti; Francesca Lenzarini; Claudia Kusmic
Journal:  World J Diabetes       Date:  2015-06-25

5.  Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors.

Authors:  Xue Li; Heng Liu; Li Zhao; Junling Liu; Li Cai; Lei Liu; Weiguo Zhang
Journal:  Br J Radiol       Date:  2016-12-08       Impact factor: 3.039

Review 6.  Adverse reactions to iodinated contrast media.

Authors:  Wendy Bottinor; Pritam Polkampally; Ion Jovin
Journal:  Int J Angiol       Date:  2013-09

Review 7.  Cardiac CT Imaging of Plaque Vulnerability: Hype or Hope?

Authors:  Martin J Willemink; Tim Leiner; Pál Maurovich-Horvat
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

8.  Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.

Authors:  Chirag R Parikh; Caroline Liu; Maria K Mor; Paul M Palevsky; James S Kaufman; Heather Thiessen Philbrook; Steven D Weisbord
Journal:  Am J Kidney Dis       Date:  2019-09-20       Impact factor: 8.860

9.  Monitoring non-immediate allergic reactions to iodine contrast media.

Authors:  M J Torres; C Mayorga; J A Cornejo-Garcia; S Lopez; P Chaves; C Rondon; T Fernandez; M Blanca
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

Review 10.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.